CL2010001416A1 - Uso de una composicion para el suministro de una hormona, peptido o proteina bactericida o peptido o proteina insecticida que comprende una celula algal deshabilitada que expresa dicha hormona, peptido o proteina para inducir crecimiento mejorado, actividad antibacteriana o insecticida (div.sol.no.1360-02). - Google Patents

Uso de una composicion para el suministro de una hormona, peptido o proteina bactericida o peptido o proteina insecticida que comprende una celula algal deshabilitada que expresa dicha hormona, peptido o proteina para inducir crecimiento mejorado, actividad antibacteriana o insecticida (div.sol.no.1360-02).

Info

Publication number
CL2010001416A1
CL2010001416A1 CL2010001416A CL2010001416A CL2010001416A1 CL 2010001416 A1 CL2010001416 A1 CL 2010001416A1 CL 2010001416 A CL2010001416 A CL 2010001416A CL 2010001416 A CL2010001416 A CL 2010001416A CL 2010001416 A1 CL2010001416 A1 CL 2010001416A1
Authority
CL
Chile
Prior art keywords
peptide
protein
hormone
insecticidal
div
Prior art date
Application number
CL2010001416A
Other languages
English (en)
Inventor
Rchard T Sayre
Richard E Wagner
Surasak Siripornadulsil
Carlos Farias
Original Assignee
Phycotransgenics Llc The Ohio State Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phycotransgenics Llc The Ohio State Univ filed Critical Phycotransgenics Llc The Ohio State Univ
Publication of CL2010001416A1 publication Critical patent/CL2010001416A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Botany (AREA)

Abstract

Uso de una composición para el suministro de una hormona, péptido o proteína bactericida o péptido o proteína insecticida que comprende una célula algal deshabilitada que expresa dicha hormona, péptido o proteína para inducir crecimiento mejorado, actividad antibacteriana o insecticida (Div.Sol.No.1360-02).
CL2010001416A 2000-06-20 2010-12-10 Uso de una composicion para el suministro de una hormona, peptido o proteina bactericida o peptido o proteina insecticida que comprende una celula algal deshabilitada que expresa dicha hormona, peptido o proteina para inducir crecimiento mejorado, actividad antibacteriana o insecticida (div.sol.no.1360-02). CL2010001416A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21275700P 2000-06-20 2000-06-20
US09/885,392 US20030022359A1 (en) 2000-06-20 2001-06-20 Transgenic algae for delivering antigens to an animal

Publications (1)

Publication Number Publication Date
CL2010001416A1 true CL2010001416A1 (es) 2011-04-25

Family

ID=22792303

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010001416A CL2010001416A1 (es) 2000-06-20 2010-12-10 Uso de una composicion para el suministro de una hormona, peptido o proteina bactericida o peptido o proteina insecticida que comprende una celula algal deshabilitada que expresa dicha hormona, peptido o proteina para inducir crecimiento mejorado, actividad antibacteriana o insecticida (div.sol.no.1360-02).

Country Status (4)

Country Link
US (6) US20030022359A1 (es)
AU (1) AU2001269936A1 (es)
CL (1) CL2010001416A1 (es)
WO (1) WO2001098335A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269936A1 (en) * 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
MXPA03008563A (es) 2001-03-23 2005-03-07 Advanced Bionutrition Alimentos microbianos para acuacultural y agricultura.
US20090215179A1 (en) * 2001-07-20 2009-08-27 Transalgae Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
US7807144B2 (en) 2001-09-05 2010-10-05 Academia Sinica Oral vaccines
US6872386B2 (en) * 2001-09-05 2005-03-29 Academia Sinica Oral vaccines
US20070148166A1 (en) * 2002-05-13 2007-06-28 Wu Madeline C S Scfvs in photosynthetic microbes
US20060120999A1 (en) * 2002-09-16 2006-06-08 Dhar Arun K Protein and peptide expression for passive immunity
US20070059808A1 (en) * 2003-09-09 2007-03-15 Aqua Bounty Technologies, Inc. Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
US7678561B2 (en) * 2006-05-09 2010-03-16 The Scripps Research Institute Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
US8216593B2 (en) 2006-09-16 2012-07-10 Board Of Regents, The University Of Texas System Parasite vaccine
US20090088726A1 (en) * 2007-09-28 2009-04-02 Microsoft Corporation Symbiotic biological systems as platforms for sensing, production, and intervention
AU2009250016A1 (en) * 2008-05-23 2009-11-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Generation of production strains that efficiently express nuclear transgenes
WO2009149470A1 (en) * 2008-06-06 2009-12-10 Aurora Biofuels, Inc. Vcp-based vectors for algal cell transformation
US8969066B2 (en) * 2008-06-27 2015-03-03 Sapphire Energy, Inc. Induction of flocculation in photosynthetic organisms
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
US20100183523A1 (en) 2009-01-22 2010-07-22 Wagner Richard E Dental composition and method
EP2210582B1 (en) * 2009-01-22 2019-09-18 Solarvest Bioenergy Inc. Dental composition comprising algae and method for producing thereof
US8314228B2 (en) 2009-02-13 2012-11-20 Aurora Algae, Inc. Bidirectional promoters in Nannochloropsis
US8809046B2 (en) 2011-04-28 2014-08-19 Aurora Algae, Inc. Algal elongases
US8865468B2 (en) 2009-10-19 2014-10-21 Aurora Algae, Inc. Homologous recombination in an algal nuclear genome
US8709765B2 (en) * 2009-07-20 2014-04-29 Aurora Algae, Inc. Manipulation of an alternative respiratory pathway in photo-autotrophs
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
EP2633049B1 (en) 2010-10-27 2018-10-10 Harrisvaccines Inc Methods and compositions to protect aquatic invertebrates from disease
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
MY153741A (en) * 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
US8722359B2 (en) 2011-01-21 2014-05-13 Aurora Algae, Inc. Genes for enhanced lipid metabolism for accumulation of lipids
JP2014519810A (ja) 2011-04-28 2014-08-21 オーロラ アルギー，インコーポレイテッド 藻類のデサチュラーゼ
US9422347B2 (en) 2011-06-06 2016-08-23 The Regents Of The University Of California Algal produced malarial transmission blocking vaccines
US9358283B2 (en) 2011-10-28 2016-06-07 The Regents Of The University Of California Diatom-based vaccines
WO2013166065A1 (en) 2012-04-30 2013-11-07 Aurora Algae, Inc. ACP Promoter
US8758774B2 (en) * 2012-07-20 2014-06-24 Kuwait Institute For Scientific Research Bivalent vaccine for marine fish and method for making the same
WO2014030165A1 (en) 2012-08-23 2014-02-27 Transalgae Israel Ltd. Transgenic microalgae and use thereof for oral delivery of proteins
DE102014200922A1 (de) * 2014-01-20 2015-07-23 Fim Biotech Gmbh Verwendung von Tonmineral als Futterzusatzstoff und/oder als Ergänzungsfutter für aquatische Organismen
CA2935635C (en) * 2014-02-12 2023-05-09 Transalgae Israel Ltd. Algal based edible vaccines
US10047371B2 (en) * 2014-02-19 2018-08-14 The Regents Of The University Of California Colostrum/milk protein compositions
EP3140401A2 (en) 2014-05-04 2017-03-15 Forrest Innovations Ltd. Compositions for mosquito control and uses of same
CN104946647A (zh) * 2015-06-08 2015-09-30 南京理工大学 一种莱茵衣藻基因间表达处理元件
EP3322798A4 (en) 2015-07-14 2019-03-06 Transalgae Israel Ltd. TRANSGENIC MICROALGUES AND THEIR USE AS A DELIVERY OF INTERFERENCE RNA MOLECULE DELIVERY
US10692126B2 (en) * 2015-11-17 2020-06-23 Nio Usa, Inc. Network-based system for selling and servicing cars
US10892942B2 (en) 2016-01-22 2021-01-12 Equinix, Inc. Container-based cloud exchange disaster recovery
GB201616087D0 (en) * 2016-09-21 2016-11-02 Tomalgae Cvba Algae comprising therapeutic and/or nutritional agents
EP3949982A4 (en) * 2019-03-29 2022-12-14 Japan Science and Technology Agency DRUG RELEASE COMPOSITION
CN110117544A (zh) * 2019-04-24 2019-08-13 中国热带农业科学院热带生物技术研究所 可防控石斑鱼神经坏死病的转基因微藻、饲料及应用
CN110438054A (zh) * 2019-07-26 2019-11-12 上海海洋大学 vp19转基因蓝藻及其在制备防治对虾白斑综合征病毒药物中的用途

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678154A (en) * 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) * 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
IL70022A0 (en) * 1982-11-08 1984-01-31 Standard Oil Co Method for introducing foreign genes into green algae cells utilizing t-dna of agrobacterium
US4992207A (en) * 1984-12-03 1991-02-12 Bio-Recovery Systems, Inc. Composition for extraction of metal ions and oxanions
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
JPH0272881A (ja) 1988-05-05 1990-03-13 Scripps Clinic Res Found クラミドモナス　ラインハーティを形質転換する方法およびシステム
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
WO1990002484A1 (en) * 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
US5804408A (en) * 1991-03-13 1998-09-08 Yoshihide Hagiwara Expression of human SOD in blue green algae
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5281422A (en) * 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5670349A (en) * 1993-08-02 1997-09-23 Virginia Tech Intellectual Properties, Inc. HMG2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
US5661017A (en) * 1993-09-14 1997-08-26 Dunahay; Terri Goodman Method to transform algae, materials therefor, and products produced thereby
GB9414118D0 (en) * 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
US5871751A (en) 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US5821087A (en) * 1995-03-30 1998-10-13 Merck & Co., Inc. Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
EP1018977B1 (en) * 1995-05-26 2004-12-08 SurModics, Inc. Method and implantable article for promoting endothelialization
US5670191A (en) 1995-09-26 1997-09-23 Church & Dwight Co., Inc. Aliphatic amide feed supplement for ruminants
US5686125A (en) * 1995-10-31 1997-11-11 Kalmbach Feeds, Inc. Granular anionic dry cow product
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
WO1997039106A1 (en) * 1996-04-12 1997-10-23 Martek Biosciences Corporation Methods and tools for transformation of eukaryotic algae
JPH10150984A (ja) 1996-11-19 1998-06-09 Hagiwara Yoshihide 抗体分子の製造方法
CA2346011C (en) * 1997-10-10 2009-01-20 Drexel University Hybrid nanofibril matrices for use as tissue engineering devices
US6027715A (en) 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4321999A (en) 1998-05-28 1999-12-13 Ohio State University Research Foundation, The Organism and method for metal recovery, remediation and separation
US6265438B1 (en) * 1998-12-03 2001-07-24 Heritage Technologies, Llc Vitamin compatible micronutrient supplement
US20030040809A1 (en) * 1999-03-20 2003-02-27 Helmut Goldmann Flat implant for use in surgery
KR20000075076A (ko) 1999-05-28 2000-12-15 최태진 형질전환된 미세조류를 이용하여 외래 단백질을 생산하는 방법
US6270347B1 (en) * 1999-06-10 2001-08-07 Rensselaer Polytechnic Institute Nanostructured ceramics and composite materials for orthopaedic-dental implants
EP1114867A1 (en) 1999-12-27 2001-07-11 Universite De Geneve Transcription regulatory sequences derived from Chlamydomonas reinhardtii
KR100366608B1 (ko) * 2000-02-15 2003-01-09 마스터진(주) 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신
JP4189620B2 (ja) 2000-03-01 2008-12-03 ライオン株式会社 歯周疾患予防・治療用口腔用組成物
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
AU2001269936A1 (en) 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
US6875907B2 (en) * 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
SE0003907D0 (sv) * 2000-10-27 2000-10-27 Swe Dencare Komposition för eliminering av tandsten ur munnen
NL1016779C2 (nl) * 2000-12-02 2002-06-04 Cornelis Johannes Maria V Rijn Matrijs, werkwijze voor het vervaardigen van precisieproducten met behulp van een matrijs, alsmede precisieproducten, in het bijzonder microzeven en membraanfilters, vervaardigd met een dergelijke matrijs.
US6703780B2 (en) * 2001-01-16 2004-03-09 General Electric Company Organic electroluminescent device with a ceramic output coupler and method of making the same
US6709622B2 (en) * 2001-03-23 2004-03-23 Romain Billiet Porous nanostructures and method of fabrication thereof
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
AU2002257289A1 (en) * 2001-05-17 2002-11-25 The Board Of Trustees Of The Leland Stanford Junior University Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
FR2849596B1 (fr) 2003-01-08 2005-02-11 Oreal Composition pour le traitement d'une peau a tendance acneique
KR101497160B1 (ko) 2006-08-11 2015-02-27 유니버시티 오브 제네바 단백질 발현 또는 억제를 위한 시스템, 방법 및 장치
US7465784B2 (en) * 2006-10-26 2008-12-16 Board Of Regents Of The University Of Nebraska Antimicrobial peptides and methods of identifying the same

Also Published As

Publication number Publication date
US8282915B2 (en) 2012-10-09
US7410637B2 (en) 2008-08-12
US20090098149A1 (en) 2009-04-16
WO2001098335A3 (en) 2002-05-16
US20170202940A1 (en) 2017-07-20
US20140017272A1 (en) 2014-01-16
US20030211089A1 (en) 2003-11-13
WO2001098335A2 (en) 2001-12-27
US20030022359A1 (en) 2003-01-30
AU2001269936A1 (en) 2002-01-02
US20140127254A1 (en) 2014-05-08

Similar Documents

Publication Publication Date Title
CL2010001416A1 (es) Uso de una composicion para el suministro de una hormona, peptido o proteina bactericida o peptido o proteina insecticida que comprende una celula algal deshabilitada que expresa dicha hormona, peptido o proteina para inducir crecimiento mejorado, actividad antibacteriana o insecticida (div.sol.no.1360-02).
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
AR047757A1 (es) Aminoacidos n,n-dihalogenados y derivados
DE60118885D1 (de) Nitratsalze von antimikrobiellen wirkstoffen
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
CL2008003939A1 (es) Uso de escitalopram o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento de ansiedad social (divisional de la solicitud 1799-00).
HN1999000124A (es) Derivados de pirazol substituido.
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
CU23260B7 (es) PREPARADO FARMACéUTICO DE MOXIFLOXACINA
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
BR0111718A (pt) Peptìdeos quimicamente modificados, composições e métodos de produção e uso
CL2010000223A1 (es) Mezcla herbicida que contiene tritosulfurona o una sal de la misma y por lo menos otro herbicida seleccionado entre flucarbazona y procarbazona o sales de las mismas; procedimiento para controlar el crecimiento de plantas indeseadas; y su uso (div. sol. 2128-01).
PT1089704E (pt) Locao tricologica para aplicacao topica
DE60123100D1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
ES2164902T3 (es) Mezclas fungicidas.
AU2002330850A1 (en) Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
ES2192779T3 (es) Modificacion cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida y su uso como antiepileptico.
ECSP066649A (es) Preparado efervescente de una sustancia básica farmacéuticamente activa
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
ITTO20010370A0 (it) Porzione di gamba per una sedia per barbiere o per istituto di bellezza.
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
ES2194744T3 (es) Derivados de quinocardina, su procedimiento de preparacion y su aplicacion como antifungicos.
AR036679A1 (es) Formulaciones y uso de las mismas